2023 annual financial data
Tonix Pharmaceuticals Holding 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,313.12%.
Operating income was -118,380,000 USD and net income was -116,658,000 USD.
Operating cash flow was -102,003,000 USD.
Get free Tonix Pharmaceuticals Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,768,000 USD
- Operating income
- -118,380,000 USD
- Net income
- -116,658,000 USD
- Operating cash flow
- -102,003,000 USD